RE:Kumtor sale whitepaper - Centerra shareprice rerate?Worth reading the whole doc but here's some of the meat: Benefits to Centerra Shareholders
Proposal represents a 58% premium to the implied market value of Kumtor (~US$507 mm)
Sale of an asset that has been the primary source of negative publicity for Centerra in recent years, potentially leading to a re-rating in its share price
Rebalances portfolio toward North America
Cash consideration can be used to accelerate the development of North American growth assets
Enhances capital structure / liquidity